Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Low-Energy Virtual Monoenergetic Images Derived From Dual-Energy Computed Tomography in Tumor Segmentation for Head and Neck Radiation Therapy: A Contouring Study.

Advances in radiation oncology·2026
Same author

Parent Experiences Accessing Inpatient Clinical Notes on a Pediatric Oncology Service.

Hospital pediatrics·2026
Same author

Regenerative Nodule as a Diagnostic Dilemma in the Neonate With Acute Liver Failure and a Focal Liver Lesion.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2026
Same author

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Related Experiment Video

Updated: Apr 7, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K

Follicular Dendritic Cell Sarcoma in an Adolescent Patient.

Hannah Glanz1, Allison Weisnicht1, Kristin Bradley2

  • 1Department of Pediatrics, Division of Pediatric Hematology, Oncology, Transplant and Cellular Therapy, University of Wisconsin School of Medicine and Public Health, UW Carbone Cancer Center, Madison, WI.

Journal of Pediatric Hematology/Oncology
|April 6, 2026
PubMed
Summary

Follicular dendritic cell sarcoma (FDCS) is a rare pediatric cancer. This case study shows chemotherapy can be effective for multiply-relapsed FDCS in adolescents, highlighting the need for further treatment research.

Keywords:
follicular dendritic cell sarcomarare diagnosissarcomasolid tumor

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Related Experiment Videos

Last Updated: Apr 7, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Area of Science:

  • Oncology
  • Pediatric Oncology
  • Cancer Research

Background:

  • Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm predominantly affecting adults.
  • Pediatric cases of FDCS are exceptionally rare, with only nine reported previously.
  • The rarity of FDCS contributes to a lack of standardized treatment protocols.

Purpose of the Study:

  • To report a case of multiply-relapsed Follicular dendritic cell sarcoma in an adolescent patient.
  • To evaluate the efficacy of chemotherapy in a pediatric patient with advanced FDCS.
  • To contribute to the limited understanding of FDCS treatment in children and adolescents.

Main Methods:

  • Case presentation of an adolescent diagnosed with multiply-relapsed Follicular dendritic cell sarcoma.
  • Administration of chemotherapy as a treatment modality.
  • Monitoring of patient response to chemotherapy.

Main Results:

  • The adolescent patient with multiply-relapsed FDCS showed a favorable response to chemotherapy.
  • Chemotherapy demonstrated efficacy in managing advanced or recurrent FDCS in this pediatric case.
  • This case suggests chemotherapy as a viable option for select pediatric FDCS patients.

Conclusions:

  • Wide local excision may be curative for some FDCS cases.
  • Further research is necessary to establish optimal adjuvant chemotherapy and radiation strategies for FDCS.
  • Advancements in genetic research may pave the way for targeted therapies for FDCS in the future.